Changes in proportionate cardiovascular mortality in patients with chronic infectious and inflammatory conditions in the United States, 1999–2018
Abstract Treatment options for several chronic infectious and inflammatory conditions have expanded in recent years. This may have implications for evolving competing risks for chronic inflammation-associated comorbidities, including cardiovascular diseases (CVDs). Yet sparse data exist on patterns...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2021-12-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-021-03407-4 |
| _version_ | 1819096191631097856 |
|---|---|
| author | Jacob W. Groenendyk Adovich S. Rivera Arjun Sinha Donald M. Lloyd-Jones Matthew J. Feinstein |
| author_facet | Jacob W. Groenendyk Adovich S. Rivera Arjun Sinha Donald M. Lloyd-Jones Matthew J. Feinstein |
| author_sort | Jacob W. Groenendyk |
| collection | DOAJ |
| description | Abstract Treatment options for several chronic infectious and inflammatory conditions have expanded in recent years. This may have implications for evolving competing risks for chronic inflammation-associated comorbidities, including cardiovascular diseases (CVDs). Yet sparse data exist on patterns over time in cardiovascular mortality for chronic infectious and inflammatory conditions. We used data from the Centers for Disease Control and Prevention 1999–2018 Multiple Causes of Death database to investigate patterns in CVD mortality from January 1, 1999 to December 31, 2018 in several infectious and inflammatory conditions. Specifically, we determined age-adjusted proportionate CVD mortality separately for patients with the following conditions (as well as the general population): hepatitis C virus (HCV), human immunodeficiency virus (HIV), inflammatory bowel diseases (IBD), psoriasis (PSO), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE). Proportionate CVD mortality differed significantly in 1999 and 2018 for each condition compared with the general population (p < 0.0001). Proportionate CVD mortality decreased steadily in the general population (40.9 to 30.6%) but increased for patients with HCV (7.0 to 10.2%) and HIV (1.9 to 6.7%). For IBD, PSO, RA, and SLE, proportionate CVD mortality initially decreased followed by plateauing or increasing rates. Underlying disease-specific pathophysiologies, changes in natural history, and competing risks of chronic end-organ diseases contributing to these differences merit further study. |
| first_indexed | 2024-12-21T23:55:17Z |
| format | Article |
| id | doaj.art-4248c05477dd40d6855afb4386d84ad6 |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-12-21T23:55:17Z |
| publishDate | 2021-12-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-4248c05477dd40d6855afb4386d84ad62022-12-21T18:45:49ZengNature PortfolioScientific Reports2045-23222021-12-011111810.1038/s41598-021-03407-4Changes in proportionate cardiovascular mortality in patients with chronic infectious and inflammatory conditions in the United States, 1999–2018Jacob W. Groenendyk0Adovich S. Rivera1Arjun Sinha2Donald M. Lloyd-Jones3Matthew J. Feinstein4Department of Medicine, Northwestern University Feinberg School of MedicineDepartment of Preventive Medicine, Northwestern University Feinberg School of MedicineDepartment of Medicine, Northwestern University Feinberg School of MedicineDepartment of Medicine, Northwestern University Feinberg School of MedicineDepartment of Medicine, Northwestern University Feinberg School of MedicineAbstract Treatment options for several chronic infectious and inflammatory conditions have expanded in recent years. This may have implications for evolving competing risks for chronic inflammation-associated comorbidities, including cardiovascular diseases (CVDs). Yet sparse data exist on patterns over time in cardiovascular mortality for chronic infectious and inflammatory conditions. We used data from the Centers for Disease Control and Prevention 1999–2018 Multiple Causes of Death database to investigate patterns in CVD mortality from January 1, 1999 to December 31, 2018 in several infectious and inflammatory conditions. Specifically, we determined age-adjusted proportionate CVD mortality separately for patients with the following conditions (as well as the general population): hepatitis C virus (HCV), human immunodeficiency virus (HIV), inflammatory bowel diseases (IBD), psoriasis (PSO), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE). Proportionate CVD mortality differed significantly in 1999 and 2018 for each condition compared with the general population (p < 0.0001). Proportionate CVD mortality decreased steadily in the general population (40.9 to 30.6%) but increased for patients with HCV (7.0 to 10.2%) and HIV (1.9 to 6.7%). For IBD, PSO, RA, and SLE, proportionate CVD mortality initially decreased followed by plateauing or increasing rates. Underlying disease-specific pathophysiologies, changes in natural history, and competing risks of chronic end-organ diseases contributing to these differences merit further study.https://doi.org/10.1038/s41598-021-03407-4 |
| spellingShingle | Jacob W. Groenendyk Adovich S. Rivera Arjun Sinha Donald M. Lloyd-Jones Matthew J. Feinstein Changes in proportionate cardiovascular mortality in patients with chronic infectious and inflammatory conditions in the United States, 1999–2018 Scientific Reports |
| title | Changes in proportionate cardiovascular mortality in patients with chronic infectious and inflammatory conditions in the United States, 1999–2018 |
| title_full | Changes in proportionate cardiovascular mortality in patients with chronic infectious and inflammatory conditions in the United States, 1999–2018 |
| title_fullStr | Changes in proportionate cardiovascular mortality in patients with chronic infectious and inflammatory conditions in the United States, 1999–2018 |
| title_full_unstemmed | Changes in proportionate cardiovascular mortality in patients with chronic infectious and inflammatory conditions in the United States, 1999–2018 |
| title_short | Changes in proportionate cardiovascular mortality in patients with chronic infectious and inflammatory conditions in the United States, 1999–2018 |
| title_sort | changes in proportionate cardiovascular mortality in patients with chronic infectious and inflammatory conditions in the united states 1999 2018 |
| url | https://doi.org/10.1038/s41598-021-03407-4 |
| work_keys_str_mv | AT jacobwgroenendyk changesinproportionatecardiovascularmortalityinpatientswithchronicinfectiousandinflammatoryconditionsintheunitedstates19992018 AT adovichsrivera changesinproportionatecardiovascularmortalityinpatientswithchronicinfectiousandinflammatoryconditionsintheunitedstates19992018 AT arjunsinha changesinproportionatecardiovascularmortalityinpatientswithchronicinfectiousandinflammatoryconditionsintheunitedstates19992018 AT donaldmlloydjones changesinproportionatecardiovascularmortalityinpatientswithchronicinfectiousandinflammatoryconditionsintheunitedstates19992018 AT matthewjfeinstein changesinproportionatecardiovascularmortalityinpatientswithchronicinfectiousandinflammatoryconditionsintheunitedstates19992018 |